Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities.

Trudzinski, Franziska C; Kellerer, Christina; Jörres, Rudolf A; Alter, Peter; Lutter, Johanna I; Trinkmann, Frederik; Herth, Felix J F; Frankenberger, Marion; Watz, Henrik; Vogelmeier, Claus F; Kauczor, Hans-Ulrich; Welte, Tobias; Behr, Jürgen; Bals, Robert; Kahnert, Kathrin

doi:10.1007/s00392-021-01915-x

Lehrstuhl für Allgemeinmedizin (Prof. Schneider)

Zurück
Zurück zum Anfang der Trefferliste
Dauerhafter Link zum angezeigten Objekt

Titel:: Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities.
Dokumenttyp:: Article; Journal Article
Autor(en):: Trudzinski, Franziska C; Kellerer, Christina; Jörres, Rudolf A; Alter, Peter; Lutter, Johanna I; Trinkmann, Frederik; Herth, Felix J F; Frankenberger, Marion; Watz, Henrik; Vogelmeier, Claus F; Kauczor, Hans-Ulrich; Welte, Tobias; Behr, Jürgen; Bals, Robert; Kahnert, Kathrin
Abstract:: BACKGROUND: In chronic obstructive pulmonary disease (COPD), gender-specific differences in the prevalence of symptoms and comorbidity are known. RESEARCH QUESTION: We studied whether the relationship between these characteristics depended on gender and carried diagnostic information regarding cardiac comorbidities. STUDY DESIGN AND METHODS: The analysis was based on 2046 patients (GOLD grades 1-4, 795 women; 38.8%) from the COSYCONET COPD cohort. Assessments comprised the determination of clinical history, comorbidities, lung function, COPD Assessment Test (CAT) and modified Medical Research Council dyspnea scale (mMRC). Using multivariate regression analyses, gender-specific differences in the relationship between symptoms, single CAT items, comorbidities and functional alterations were determined. To reveal the relationship to cardiac disease (myocardial infarction, or heart failure, or coronary artery disease) logistic regression analysis was performed separately in men and women. RESULTS: Most functional parameters and comorbidities, as well as CAT items 1 (cough), 2 (phlegm) and 5 (activities), differed significantly (p < 0.05) between men and women. Beyond this, the relationship between functional parameters and comorbidities versus symptoms showed gender-specific differences, especially for single CAT items. In men, item 8 (energy), mMRC, smoking status, BMI, age and spirometric lung function was related to cardiac disease, while in women primarily age was predictive. INTERPRETATION: Gender-specific differences in COPD not only comprised differences in symptoms, comorbidities and functional alterations, but also differences in their mutual relationships. This was reflected in different determinants linked to cardiac disease, thereby indicating that simple diagnostic information might be used differently in men and women. CLINICAL TRIAL REGISTRATION: The cohort study is registered on ClinicalTrials.gov with identifier NCT01245933 and on GermanCTR.de with identifier DRKS00000284, date of registration November 23, 2010. Further information can be obtained on the website http://www.asconet.net .
Zeitschriftentitel:: Clin Res Cardiol
Jahr:: 2023
Band / Volume:: 112
Heft / Issue:: 2
Seitenangaben Beitrag:: 177-186
Volltext / DOI:: doi:10.1007/s00392-021-01915-x
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/34331588
Print-ISSN:: 1861-0684
TUM Einrichtung:: 587; 604; Lehrstuhl für Allgemeinmedizin (Prof. Schneider)
BibTeX